Cosmos Health vs Henry Schein
Henry Schein is the larger business, with $13.18bn of revenue in fiscal 2025 against $65.3m for Cosmos Health (202.0 times as much). Cosmos Health grew faster (19.9% against 4.0%). Henry Schein kept more of each dollar of sales as profit: a net margin of 3.0% against -29.3%.
| Latest fiscal year | Cosmos HealthCOSM, 2025 | Henry ScheinHSIC, 2025 |
|---|---|---|
| Revenue | $65.3m | $13.18bn |
| Revenue growth | 19.9% | 4.0% |
| Net income | −$19.1m | $398m |
| Operating margin | — | 5.0% |
| Net margin | -29.3% | 3.0% |
| Return on equity | -89.1% | 12.0% |
| Free cash flow | −$8.5m | $573m |
| Cash | $715,674 | $156m |
| Total debt | $15.6m | $3.11bn |
| Debt to equity | — | 95.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $850m |
| Employees | 163 | 25,000 |
| Market value | $24.4m | $9.21bn |
| Price vs our value range | — | Within our value range |
| Moat score | 22 (Weak) | 57 (Moderate) |
| Insider trades, 12 months | 21 buys, 0 sales | 1 buys, 10 sales |